A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma

  • A. M. Evens
  • , K. R. Carson
  • , J. Kolesar
  • , C. Nabhan
  • , I. Helenowski
  • , N. Islam
  • , B. Jovanovic
  • , P. M. Barr
  • , P. F. Caimi
  • , S. A. Gregory
  • , L. I. Gordon

Research output: Contribution to journal › Article › peer-review

54   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Neuroscience